tldrdailynews.com logo
Tag

Hepatitis B

All articles tagged with #hepatitis b

Philadelphia dental clinic closure prompts HIV and hepatitis testing for patients
health4 days ago

Philadelphia dental clinic closure prompts HIV and hepatitis testing for patients

Philadelphia health officials urge patients of Smiles at Rittenhouse Square to get tested for HIV and hepatitis after investigators found unsanitary practices; the clinic is closed and the dentist's license suspended; potential exposure window is April 2025 through May 2026; no linked cases identified yet, but risk is considered low but real; officials expect hundreds of patients may be affected and have set up a helpline at 215-685-5488; hepatitis B vaccination offers protection if exposed, while there are no vaccines for HIV or hepatitis C; testing may require multiple blood draws depending on timing.

via ABC News - Breaking News, Latest News and Videos|
#dental-clinic#health#hepatitis-b
Philly dental clinic shut over unsanitary conditions; patients urged to test for HIV and hepatitis
local6 days ago

Philly dental clinic shut over unsanitary conditions; patients urged to test for HIV and hepatitis

Philadelphia health officials suspended the Smiles at Rittenhouse Square license and closed the clinic after unsanitary conditions were found. Former patients who visited from April 2025 through May 2026 will be notified by mail to seek testing for HIV, Hepatitis B and Hepatitis C; a hotline (215-685-5488) is available for questions. No infections have been confirmed, and the clinic will not reopen until infection-control remediation is completed and the dentist’s license is reinstated. A separate investigation by the Pennsylvania Department of State is underway, and Dr. Kirti Chopra is cooperating with authorities.

via CBS News|
#hepatitis-b#hepatitis-c#hiv
Birth Dose Backslide: Hepatitis B Vaccination Slumps in U.S. Hospitals
public-health2 months ago

Birth Dose Backslide: Hepatitis B Vaccination Slumps in U.S. Hospitals

A JAMA study of 12.4 million US newborns found the hepatitis B birth-dose rate dropped from 83.5% to 73.2% from 2023 to mid-2025, implying hundreds of thousands fewer babies vaccinated and potential rises in infant infections. The decline aligns with rising vaccine skepticism linked to the Covid era, and follows the CDC’s shift to shared decision-making for several vaccines, producing uneven state responses. Experts warn the US health system lacks the infrastructure to match more universal, registry-backed vaccination models seen in other countries.

via Vox|
#cdc#hepatitis-b#public-health
politics2 months ago

Vaccines at the Center as Surgeon General Nominee Faces Senate Scrutiny

At a Senate confirmation hearing, Casey Means, President Trump’s surgeon general nominee, was grilled over vaccines and the autism link, refused to push universal vaccination, and urged parents to discuss shots with doctors while acknowledging vaccines’ life-saving role and supporting shared clinical decision-making; lawmakers pressed on universal hepatitis B birth-dose policy and Means’s credentials, including her inactive medical license and wellness-influencer background.

via Politico|
#autism-debate#casey-means#hepatitis-b
New Documents Trace Controversial Hepatitis B Birth-Dose Study's Shortcut to CDC Approval
politics3 months ago

New Documents Trace Controversial Hepatitis B Birth-Dose Study's Shortcut to CDC Approval

A Rolling Stone investigation shows that a $1.6 million birth-dose hepatitis B vaccine study in Guinea-Bissau was moved directly from the CDC director’s office to grants management, bypassing normal scientific review and ethical oversight, amid pressure from Kennedy allies and irregular ethics approvals, drawing WHO concern and congressional scrutiny as the project remains in limbo.

via Rolling Stone|
#cdc#ethics#guinea-bissau
WHO flags unethical US-backed newborn hepatitis B trial in Guinea-Bissau
health3 months ago

WHO flags unethical US-backed newborn hepatitis B trial in Guinea-Bissau

The World Health Organization criticized and halted a US-funded hepatitis B vaccine trial in Guinea-Bissau that would compare vaccinating newborns at birth with delaying the dose to six weeks, calling the plan unethical and lacking justified scientific safeguards; the birth dose is a proven public health intervention, and about 14,000 babies were to be enrolled before the government suspended the project amid public outrage. Guinea-Bissau plans to roll out the birth-dose nationwide by 2028, with WHO support to accelerate adoption.

via BBC|
#birth-dose#ethics#guinea-bissau
Africa CDC Defends Sovereignty Over US-Backed Infant Vaccine Trial
world4 months ago

Africa CDC Defends Sovereignty Over US-Backed Infant Vaccine Trial

Africa CDC chief Jean Kaseya rebuked a US-backed plan to run an infant hepatitis B vaccine trial in Guinea-Bissau, insisting any study must be authorized by Guinea-Bissau’s National Medicines Regulatory Authority, National Ethics Committee, local IRBs, and the Ministry of Health, underscoring Africa’s sovereignty. The proposed trial would have enrolled about 14,000 newborns (7,000 vaccinated, 7,000 controls) and was funded with $1.6 million from the US HHS. Critics say such research should serve Africans’ needs and ensure standard care for controls, while the US has criticized Africa CDC as “fake and powerless.” The flare-up exposes tensions between Western funders and African health authorities over governance of research.

via Futurism|
#africa-cdc#clinical-trials#guinea-bissau
Guinea-Bissau halts US-funded birth-dose hepatitis B trial amid ethics concerns
world4 months ago

Guinea-Bissau halts US-funded birth-dose hepatitis B trial amid ethics concerns

Guinea-Bissau suspended a US-funded hepatitis B vaccine trial that would randomize about 14,000 newborns to receive a birth dose or not, pending a technical and ethical review by the national public health institute. The Bandim Health Project designed the study and it received a $1.6 million CDC grant, with the goal of evaluating broader vaccine effects ahead of the country’s planned universal birth-dose policy in 2027. While the US Health and Human Services says the trial remains on track, African scientists have questioned funding-driven dynamics and governance, arguing the design could undermine safe vaccination or reflect political pressure to limit vaccines in Africa. The dispute highlights ongoing tensions over who controls clinical research in Africa and how local health priorities are weighed against external funding interests.

via Nature|
#clinical-trials#ethics#guinea-bissau
CDC Reverses Universal Hepatitis B Vaccine Recommendation for Newborns
health5 months ago

CDC Reverses Universal Hepatitis B Vaccine Recommendation for Newborns

The CDC has officially stopped recommending universal hepatitis B vaccination for all newborns, instead advising only those born to infected mothers to receive the vaccine within 24 hours, citing informed consent concerns. This decision has faced criticism from health experts who warn it could lead to increased hepatitis B cases, reversing decades of progress in disease prevention. The change reflects broader shifts in CDC guidance under new leadership, raising concerns about scientific integrity and public health safety.

via NBC News|
#cdc#health#hepatitis-b